Neurology ReviewsFDA head calls for investigation into agency’s approval of aducanumab (Aduhelm)July 12, 2021Alzheimer's & Cognition
Neurology ReviewsFDA updates label for controversial Alzheimer’s drug aducanumab (Aduhelm)July 8, 2021Alzheimer's & Cognition
Neurology ReviewsChronic stress and genetics can raise the risk of Alzheimer’s diseaseJuly 7, 2021Alzheimer's & Cognition
Neurology ReviewsHearing loss tied to decline in physical functioningJuly 2, 2021Alzheimer's & CognitionMovement Disorders
Neurology ReviewsFDA fast-tracks lecanemab for Alzheimer’s diseaseJune 25, 2021Alzheimer's & Cognition
Neurology ReviewsFDA leader explains rationale leading to controversial Alzheimer’s drug approvalJune 25, 2021Alzheimer's & Cognition
Neurology ReviewsNo overall statin effect seen on dementia, cognition in ASPREE analysisJune 23, 2021Alzheimer's & Cognition
Neurology ReviewsMemory benefit seen with antihypertensives crossing blood-brain barrierJune 21, 2021Mixed TopicsAlzheimer's & Cognition
Neurology ReviewsIs trouble falling asleep a modifiable risk factor for dementia?June 21, 2021Sleep MedicineAlzheimer's & Cognition
Neurology ReviewsWatchdog group demands removal of FDA leaders after aducanumab approvalJune 16, 2021Alzheimer's & Cognition
Neurology ReviewsPhotobiomodulation: Evaluation in a wide range of medical specialties underwayJune 16, 2021PainAlzheimer's & CognitionParkinson's DiseaseMixed Topics
Neurology ReviewsFDA approves controversial Alzheimer’s drug aducanumab (Aduhelm)June 7, 2021Alzheimer's & Cognition
Neurology ReviewsThe end of happy hour? No safe level of alcohol for the brainMay 25, 2021Alzheimer's & CognitionMixed Topics
